CD14 and neoplasm: Exploring factors such as changes in the neutrophil phenotype or interactions between neutrophils and TAMs after RT could lead to significant breakthroughs, and future studies will require multiplex IHC or spatial transcriptomics to dissect CD14 expression within tumor cells.